Reliability and Validity Study of Urdu Version of Oxford Knee Score in Patients With Knee Osteoarthritis

Knee Osteoarthritis Clinical Trial

Official title:

Analysis of Psychometric Properties and Cultural Adaptation of Urdu Version of Oxford Knee Score in Patients With Knee Osteoarthritis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05440461
• Other study ID #: REC/FSD/0290
• Status: Completed
• Start date: May 30, 2021
• Est. completion date: November 20, 2022

Study information

• Verified date: January 2024
• Source: Riphah International University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

• To translate the Oxford knee score into Urdu language

• To evaluate the reliability and validity of Urdu Version of Oxford knee score for accessing pain and physical function in patients with knee osteoarthritis.

• To evaluate the correlation of Oxford knee score with Western Ontario McMaster universities osteoarthritis index and International Knee Documentation Committee

Description:

The original English version of Oxford Knee Score will be translated and culturally adapted as per previous recommendation. In patients with knee osteoarthritis, Urdu Version of Oxford Knee Score will be distributed among 100 participants choose a convenience sampling technique based on pre-defined inclusion and exclusion criteria. To test reliability of inter/intra observer of ultimate final Urdu Version of Oxford Knee Score will be filled from patients on the equivalent day, by 2 different bystanders, and for inter observer valuation, with an interval of 30 minutes between the first and second application. Third assessment will be carried out after 7 days of the Observer -1, for intra-observer assessment. Data will be entered and analyzed Cronbach alpha value. Test-retest reliability will be assessed using an intra-class correlation coefficient. Urdu Version of Oxford Knee Score will be evaluated for content validity, construct validity, criterion validity and responsiveness.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: November 20, 2022
• Est. primary completion date: November 20, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 35 Years to 80 Years

Eligibility

Inclusion Criteria:

• Diagnosed knee Osteoarthritis patients were included

• Both male and female patients were included

• Both unilateral and bilateral knee Osteoarthritis patients were included

• Patients were included who fulfilled the American college of rheumatology criteria

• Patients were included between the age of 35-80 Y old patients

Exclusion Criteria:

• Patients with any heart problem were excluded

• Patients with peripheral vascular injury were excluded

Related Conditions & MeSH terms

• Knee Osteoarthritis
• Osteoarthritis
• Osteoarthritis, Knee

Locations

Country	Name	City	State
Pakistan	Ripah International University	Faisalabad	Punjab

Sponsors (1)

Lead Sponsor	Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Oxford knee score	Oxford knee score is 12 items self-evaluation form which is used to evaluate the knee Osteoarthritis. Oxford knee score is used to evaluate pain and physical disability.	day 1
Primary	Western Ontario McMaster universities osteoarthritis index	Western Ontario McMaster universities osteoarthritis index is a 24 items to evaluate knee Osteoarthritis. First 5 items are used to evaluate pain, 6 and 7 items are used to evaluate stiffness and next 8 to 24 questions are used to access physical function.	day 1
Primary	International Knee Documentation Committee	International Knee Documentation Committee has 19 items. It is used to evaluate knee Osteoarthritis and ligament injuries. The International Knee Documentation Committee is a patient-completed tool, which contains sections on knee symptoms (7 items), function (2 items), and sports activities (2 items). Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms)	day 1